Connection
Sridharan Raghavan to Biomarkers
This is a "connection" page, showing publications Sridharan Raghavan has written about Biomarkers.
|
|
Connection Strength |
|
 |
|
 |
|
0.018 |
|
|
|
-
Basu S, Raghavan S, Wexler DJ, Berkowitz SA. Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial. Diabetes Care. 2018 03; 41(3):604-612.
Score: 0.018